• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与冠心病患者戒烟相关的因素:EuroAspire IV 调查德国亚组的队列分析。

Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey.

机构信息

Comprehensive Heart Failure Center, University and University Hospital Würzburg, Am Schwarzenberg 15, Haus A15, D-97078, Würzburg, Germany.

Institute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.

出版信息

BMC Cardiovasc Disord. 2020 Mar 30;20(1):152. doi: 10.1186/s12872-020-01429-w.

DOI:10.1186/s12872-020-01429-w
PMID:32228474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7106891/
Abstract

BACKGROUND

Tobacco smoking is one of the most important risk factors of coronary heart disease (CHD). Hence, smoking cessation is considered pivotal in the prevention of CHD. The current study aimed to evaluate smoking cessation patterns and determine factors associated with smoking cessation in patients with established CHD.

METHODS

The fourth European Survey of Cardiovascular Disease Prevention and Diabetes investigated quality of CHD care in 24 countries across Europe in 2012/13. In the German subset, smoking cessation patterns and clinical characteristics were repetitively assessed a) during index event due to CHD by medical record abstraction, b) as part of a face-to-face interview 6 to 36 months after the index event (i.e. baseline visit), and c) by telephone-based follow-up interview two years after the baseline visit. Logistic regression analysis was performed to search for factors determining smoking status at the time of the telephone interview.

RESULTS

Out of 469 participants available for follow-up, 104 (22.2%) had been classified as current smokers at the index event. Of those, 65 patients (62.5%) had quit smoking at the time of the telephone interview, i.e., after a median observation period of 3.5 years (quartiles 3.0, 4.1). Depressed mood at baseline visit and higher education level were less prevalent amongst quitters vs non-quitters (17.2% vs 35.9%, p = 0.03 and 15.4% vs 33.3%, p = 0.03), cardiac rehabilitation programs were more frequently attended by quitters (83.1% vs 48.7%, p < 0.001), and there was a trend for a higher prevalence of diabetes at baseline visit in quitters (37.5% vs 20.5%, p = 0.07). In the final multivariable model, cardiac rehabilitation was associated with smoking cessation (OR 5.19; 95%CI 1.87 to 14.46; p = 0.002).

DISCUSSION

Attending a cardiac rehabilitation program after a cardiovascular event was associated with smoking cessation supporting its use as a platform for smoking cessation counseling and relapse prevention.

摘要

背景

吸烟是冠心病(CHD)最重要的危险因素之一。因此,戒烟被认为是预防 CHD 的关键。本研究旨在评估已确诊 CHD 患者的戒烟模式,并确定与戒烟相关的因素。

方法

第四次欧洲心血管疾病预防和糖尿病调查于 2012/13 年在欧洲 24 个国家调查了 CHD 护理质量。在德国子样本中,通过病历摘录在 CHD 首发事件期间反复评估戒烟模式和临床特征,a);在首发事件后 6 至 36 个月(即基线访视)进行面对面访谈,b);通过基线访视两年后的电话随访访谈,c)。采用逻辑回归分析寻找决定电话访谈时吸烟状况的因素。

结果

在可进行随访的 469 名参与者中,有 104 名(22.2%)在首发事件时被归类为当前吸烟者。其中,65 名患者(62.5%)在电话访谈时已戒烟,即中位观察期为 3.5 年后(四分位数 3.0,4.1)。与未戒烟者相比,戒烟者在基线访视时的抑郁情绪(17.2%比 35.9%,p=0.03)和较高的教育水平(15.4%比 33.3%,p=0.03)更为少见,戒烟者更常参加心脏康复计划(83.1%比 48.7%,p<0.001),且在基线访视时,戒烟者的糖尿病患病率有增高趋势(37.5%比 20.5%,p=0.07)。在最终的多变量模型中,心脏康复与戒烟相关(OR 5.19;95%CI 1.87 至 14.46;p=0.002)。

讨论

在心血管事件后参加心脏康复计划与戒烟相关,支持将其作为戒烟咨询和复发预防的平台。

相似文献

1
Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey.与冠心病患者戒烟相关的因素:EuroAspire IV 调查德国亚组的队列分析。
BMC Cardiovasc Disord. 2020 Mar 30;20(1):152. doi: 10.1186/s12872-020-01429-w.
2
Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey.欧洲冠心病患者戒烟准备度:来自 EUROASPIRE III 调查的结果。
Eur J Prev Cardiol. 2015 Sep;22(9):1212-9. doi: 10.1177/2047487314564728. Epub 2014 Dec 16.
3
Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology.欧洲冠心病患者戒烟。来自欧洲心脏病学会 EUROASPIRE IV 调查的结果:一个注册研究。
Int J Cardiol. 2018 May 1;258:1-6. doi: 10.1016/j.ijcard.2018.01.064.
4
Medical and sociodemographic factors predict persistent smoking after coronary events.医学和社会人口学因素可预测冠心病事件后的持续吸烟情况。
BMC Cardiovasc Disord. 2017 Sep 6;17(1):241. doi: 10.1186/s12872-017-0676-1.
5
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
6
Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description.两种强化戒烟和预防复发方法对冠心病患者的有效性:研究方案和基线描述。
BMC Cardiovasc Disord. 2012 May 15;12:33. doi: 10.1186/1471-2261-12-33.
7
Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey.冠心病患者心脏康复的应用和效果:来自 EUROASPIRE III 调查的结果。
Eur J Prev Cardiol. 2013 Oct;20(5):817-26. doi: 10.1177/2047487312449591. Epub 2012 Jun 19.
8
Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease.冠心病非药物二级预防的医疗卫生经济效果评估
GMS Health Technol Assess. 2009 Dec 14;5:Doc16. doi: 10.3205/hta000078.
9
Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.年轻与老年冠心病患者的二级预防——来自EUROASPIRE IV调查德国子集的见解
Int J Behav Med. 2018 Jun;25(3):283-293. doi: 10.1007/s12529-017-9691-y.
10
Passive smoking and smoking cessation among patients with coronary heart disease across Europe: results from the EUROASPIRE III survey.欧洲冠心病患者中的被动吸烟和戒烟情况:来自 EUROASPIRE III 调查的结果。
Eur Heart J. 2014 Mar;35(9):590-8. doi: 10.1093/eurheartj/eht538. Epub 2013 Dec 13.

引用本文的文献

1
Exposure to major coronary heart disease events reduces lung cancer risk: a mendelian randomization study based on a European population.暴露于主要冠心病事件可降低肺癌风险:一项基于欧洲人群的孟德尔随机化研究。
BMC Cancer. 2025 Jan 27;25(1):152. doi: 10.1186/s12885-025-13485-6.
2
Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction.首次心肌梗死患者发生复发性动脉粥样硬化性心血管疾病事件的社会经济差异及其介导因素。
Circulation. 2023 Jul 18;148(3):256-267. doi: 10.1161/CIRCULATIONAHA.123.064440. Epub 2023 Jul 17.
3
Machine learning application for predicting smoking cessation among US adults: An analysis of waves 1-3 of the PATH study.

本文引用的文献

1
Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV.德国医生关于原发性和继发性心血管疾病预防的生活方式建议:STAAB队列研究与EUROASPIRE IV德国子组的比较
Eur J Prev Cardiol. 2021 Sep 20;28(11):1175-1183. doi: 10.1177/2047487319838218. Epub 2019 Mar 19.
2
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.稳定型冠心病患者心血管事件的发生率:EUROASPIRE IV 随访研究。
Eur J Epidemiol. 2019 Mar;34(3):247-258. doi: 10.1007/s10654-018-0454-0. Epub 2018 Oct 23.
3
机器学习在美国成年人戒烟预测中的应用:PATH 研究第 1-3 波分析。
PLoS One. 2023 Jun 8;18(6):e0286883. doi: 10.1371/journal.pone.0286883. eCollection 2023.
4
Factors associated with successful smoking cessation in men with or without cardiovascular disease or cancer: Nationwide Korean population analysis.患有或未患心血管疾病或癌症的男性成功戒烟的相关因素:韩国全国人口分析。
Tob Induc Dis. 2023 Feb 20;21:28. doi: 10.18332/tid/159169. eCollection 2023.
5
Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys.糖尿病和非糖尿病冠心病患者的二级预防:来自 EUROASPIRE IV 和 V 调查医院部分的德国亚组的观察。
Clin Res Cardiol. 2023 Feb;112(2):285-298. doi: 10.1007/s00392-022-02093-0. Epub 2022 Sep 27.
Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.
依据欧洲冠心病患者参加心脏康复项目的情况评估其参与度和危险因素控制情况的决定因素:EUROASPIRE IV 调查。
Eur J Prev Cardiol. 2018 Aug;25(12):1242-1251. doi: 10.1177/2047487318781359. Epub 2018 Jun 6.
4
Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology.欧洲冠心病患者戒烟。来自欧洲心脏病学会 EUROASPIRE IV 调查的结果:一个注册研究。
Int J Cardiol. 2018 May 1;258:1-6. doi: 10.1016/j.ijcard.2018.01.064.
5
Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.年轻与老年冠心病患者的二级预防——来自EUROASPIRE IV调查德国子集的见解
Int J Behav Med. 2018 Jun;25(3):283-293. doi: 10.1007/s12529-017-9691-y.
6
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.1990年至2015年全球、区域和国家10种心血管疾病病因负担
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25. doi: 10.1016/j.jacc.2017.04.052. Epub 2017 May 17.
7
Trends in Absolute and Relative Educational Inequalities in Adult Smoking Since the Early 2000s: The Case of Germany.21 世纪初以来成人吸烟中绝对和相对教育不平等的趋势:以德国为例。
Nicotine Tob Res. 2018 Feb 7;20(3):295-302. doi: 10.1093/ntr/ntx087.
8
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南:欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组(由10个学会的代表和特邀专家组成)由欧洲心血管预防与康复协会(EACPR)特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
9
Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.欧洲冠心病患者生活方式、风险因素控制和循证药物使用的时间趋势:来自 3 项 EUROASPIRE 调查的结果,1999-2013 年。
Glob Heart. 2017 Dec;12(4):315-322.e3. doi: 10.1016/j.gheart.2015.11.003. Epub 2016 Mar 16.
10
Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption.立法禁烟以减少二手烟暴露、吸烟流行率和烟草消费带来的危害。
Cochrane Database Syst Rev. 2016 Feb 4;2(2):CD005992. doi: 10.1002/14651858.CD005992.pub3.